Iniciar Sesión Regístrate abrir menu

Bibliografía Científica

Artículos por temáticas

En este apartado encontrará una actualización mensual de Trastornos del Movimiento

4062 ARTÍCULOS , VIENDO DEL 3916 AL 3930

Regenerative cellular therapies for neurologic diseases

Levy M, Boulis N, Rao M, Svendsen CN.

Brain Res. 2016 May 1;1638(Pt A):88-96. doi: 10.1016/j.brainres.2015.06.053. Epub 2015 Jul 31.

Using Drosophila models of Huntington's disease as a translatable tool

Lewis EA, Smith GA.

J Neurosci Methods. 2016 May 30;265:89-98. doi: 10.1016/j.jneumeth.2015.07.026. Epub 2015 Aug 1.

Observational Gait Assessments in People With Neurological Disorders: A Systematic Review

Gor-García-Fogeda MD, Cano de la Cuerda R, Carratalá Tejada M, Alguacil-Diego IM, Molina-Rueda F.

Arch Phys Med Rehabil. 2016 Jan;97(1):131-40. doi: 10.1016/j.apmr.2015.07.018. Epub 2015 Aug 5.

What's wrong with my mouse cage? Methodological considerations for modeling lifestyle factors and gene-environment interactions in mice

Mo C, Renoir T, Hannan AJ.

J Neurosci Methods. 2016 May 30;265:99-108. doi: 10.1016/j.jneumeth.2015.08.008. Epub 2015 Aug 14.

A mobile, high-throughput semi-automated system for testing cognition in large non-primate animal models of Huntington disease

McBride SD, Perentos N, Morton AJ.

J Neurosci Methods. 2016 May 30;265:25-33. doi: 10.1016/j.jneumeth.2015.08.025. Epub 2015 Aug 29.

Adult-onset Sydenham's chorea or drug-induced movement disorder? A case report

Delaruelle Z, Honoré PJ, Santens P.

Acta Neurol Belg. 2016 Sep;116(3):399-400. doi: 10.1007/s13760-015-0537-6. Epub 2015 Sep 4.

The hyperkinetic movement disorder of FOXG1-related epileptic-dyskinetic encephalopathy

Cellini E, Vignoli A, Pisano T, Falchi M, Molinaro A, Accorsi P, Bontacchio A, Pinelli L, Giordano L, Guerrini R; FOXG1 Syndrome Study Group.

Dev Med Child Neurol. 2016 Jan;58(1):93-7. doi: 10.1111/dmcn.12894. Epub 2015 Sep 6.

Mitochondrial dynamics and quality control in Huntington's disease

Guedes-Dias P, Pinho BR, Soares TR, de Proença J, Duchen MR, Oliveira JM.

Neurobiol Dis. 2016 Jun;90:51-7. doi: 10.1016/j.nbd.2015.09.008. Epub 2015 Sep 24.

The effect of mild and moderate renal impairment on the pharmacokinetics of pridopidine, a new drug for Huntington's disease

Rabinovich-Guilatt L, Siegler KE, Schultz A, Halabi A, Rembratt A, Spiegelstein O.

Br J Clin Pharmacol. 2016 Feb;81(2):246-55. doi: 10.1111/bcp.12792. Epub 2015 Nov 25.

iPSC-based drug screening for Huntington's disease

Zhang N, Bailus BJ, Ring KL, Ellerby LM.

Brain Res. 2016 May 1;1638(Pt A):42-56. doi: 10.1016/j.brainres.2015.09.020. Epub 2015 Sep 30.

Neuropeptide Y: A stressful review

Reichmann F, Holzer P.

Neuropeptides. 2016 Feb;55:99-109. doi: 10.1016/j.npep.2015.09.008. Epub 2015 Sep 30.

Pial Synangiosis Ameliorates Movement Disorders in the Absence of Prior Stroke in Moyamoya Disease

Greene S, Bansal L, Coffman KA, Nardone R, Zuccoli G.

J Child Neurol. 2016 Apr;31(5):646-51. doi: 10.1177/0883073815609152. Epub 2015 Oct 8.

Large-scale brain network abnormalities in Huntington's disease revealed by structural covariance

Minkova L, Eickhoff SB, Abdulkadir A, Kaller CP, Peter J, Scheller E, Lahr J, Roos RA, Durr A, Leavitt BR, Tabrizi SJ, Klöppel S; TRACK-HD Investigators.

Hum Brain Mapp. 2016 Jan;37(1):67-80. doi: 10.1002/hbm.23014. Epub 2015 Oct 10.

Autoimmunity against dopamine receptors in neuropsychiatric and movement disorders: a review of Sydenham chorea and beyond

Cunningham MW, Cox CJ.

Acta Physiol (Oxf). 2016 Jan;216(1):90-100. doi: 10.1111/apha.12614. Epub 2015 Nov 5.

Social cognition in Huntington's disease: A meta-analysis

Bora E, Velakoulis D, Walterfang M.

Behav Brain Res. 2016 Jan 15;297:131-40. doi: 10.1016/j.bbr.2015.10.001. Epub 2015 Oct 8.

Actualización mensual Regístrese para recibir los avisos de actualización

Si quiere recomendar un artículo/publicación para completar este apartado puede hacerlo a través del formulario de contacto para su valoración.

En ningún caso la información facilitada constituye asesoramiento por parte de Zambon

Con el aval de:

Logo SEN Logo WIS

En colaboración con:

Zambon Neurociencias